| Autor: |
Fialková V; AgroBioTech Research Centre, Slovak University of Agriculture, Nitra, Slovakia., Ďúranová H; AgroBioTech Research Centre, Slovak University of Agriculture, Nitra, Slovakia., Borotová P; AgroBioTech Research Centre, Slovak University of Agriculture, Nitra, Slovakia., Klongová L; AgroBioTech Research Centre, Slovak University of Agriculture, Nitra, Slovakia., Grabacka M; Department of Biotechnology and General Technology of Foods, Faculty of Food Technology, University of Agriculture, Cracow, Poland., Speváková I; AgroBioTech Research Centre, Slovak University of Agriculture, Nitra, Slovakia. |
| Jazyk: |
angličtina |
| Zdroj: |
Nutrition and cancer [Nutr Cancer] 2024; Vol. 76 (9), pp. 760-788. Date of Electronic Publication: 2024 Jul 01. |
| DOI: |
10.1080/01635581.2024.2364391 |
| Abstrakt: |
The resistance of colorectal cancer (CRC) to conventional therapeutic modalities, such as radiation therapy and chemotherapy, along with the associated side effects, significantly limits effective anticancer strategies. Numerous epigenetic investigations have unveiled that naturally occurring stilbenes can modify or reverse abnormal epigenetic alterations, particularly aberrant DNA methylation status, offering potential avenues for preventing or treating CRC. By modulating the activity of the DNA methylation machinery components, phytochemicals may influence the various stages of CRC carcinogenesis through multiple molecular mechanisms. Several epigenetic studies, especially preclinical research, have highlighted the effective DNA methylation modulatory effects of stilbenes with minimal adverse effects on organisms, particularly in combination therapies for CRC. However, the available preclinical and clinical data regarding the effects of commonly encountered stilbenes against CRC are currently limited. Therefore, additional epigenetic research is warranted to explore the preventive potential of these phytochemicals in CRC development and to validate their therapeutic application in the prevention and treatment of CRC. This review aims to provide an overview of selected bioactive stilbenes as potential chemopreventive agents for CRC with a focus on their modulatory mechanisms of action, especially in targeting alterations in DNA methylation machinery in CRC. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
